stock price decline

Pomerantz Law Firm filed class action lawsuit against $CWH alleging securities fraud following disappointing earnings reports and dividend suspension.

Securities fraud lawsuit filed against $CWH over alleged materially false financial statements. Stock fell 41% following disappointing Q3, Q4 results and dividend suspension.

Pinterest sued for allegedly hiding tariff-related margin pressures on advertisers and subsequent $35-45M restructuring. Stock fell $12.77 across corrective disclosures.

Gemini Space Station ex-COO faces securities fraud lawsuit after allegedly selling $11.8M in shares while hiding restructuring plans. Stock down 76% from IPO.

Immutep shares plummet 82.6% after discontinuing Phase III trial for eftilagimod alfa due to futility, triggering class action investigation by Rosen Law Firm.

Disc Medicine ($IRON) shares tumbled 22% following FDA rejection of its bitopertin program. Law firm investigates potential securities violations and shareholder losses.

Babcock & Wilcox faces securities fraud lawsuit over allegedly inflating a $2.4B contract value; only $434M was guaranteed, prompting an 11.59% stock drop.

Class action lawsuit filed against $NKTR for allegedly concealing REZOLVE-AA trial protocol violations and ineligible patient enrollment. Stock fell 7.77% on trial failure announcement.

Trip.com faces securities fraud lawsuit alleging it concealed Chinese antitrust investigations. Stock fell 17.05% when probe became public January 2026.

ImmunityBio faces securities lawsuit after FDA warning letter over misleading Anktiva efficacy claims. Stock plunged 21%, erasing $2 billion in market value.

PennyMac Financial Services ($PFSI) faces securities investigation after servicing segment income crashed 76%, triggering 33% stock decline.

Immutep stock crashed 82.6% after discontinuing a Phase III trial; Rosen Law Firm investigating potential securities fraud claims for shareholders.

Sportradar faces securities investigation following Muddy Waters allegations of aiding illegal sportsbooks. Stock fell 22% after April report.

Robbins LLP files class action against Babcock & Wilcox ($BW) over alleged investor deception regarding shareholder relationships and contract legitimacy, exposing alleged disclosure failures from November 2025-March 2026.

Law firm Robbins LLP seeks lead plaintiff for class action against Camping World Holdings ($CWH) over alleged misrepresentations on inventory and demand forecasts. Stock fell 16.5% after disappointing Q4 results.

Class action lawsuit filed against $GLOB for alleged false statements. Stock fell after missed guidance, revenue decline, and $47.6M restructuring charge.

Aldeyra Therapeutics faces federal securities lawsuit alleging inadequate disclosure of failed clinical trial results for reproxalap. Stock crashed 71% after FDA rejection; investor deadline May 29, 2026.

Class action lawsuit filed against Regencell Bioscience for alleged false statements and failure to disclose DOJ investigation into trading practices.

Class action lawsuit filed against Aquestive Therapeutics after company failed to disclose FDA deficiencies blocking Anaphylm approval, triggering 37% stock decline.

Law firm Johnson Fistel investigates O-I Glass after earnings miss revealed European segment profit collapsed to near-zero, prompting 20% stock decline and guidance cuts.